Evidence map›Paper›PMID 39569381›Full record

ArticleiScience2024

Metabolic changes of human induced pluripotent stem cell-derived cardiomyocytes and teratomas after transplantation.

Yusuke Soma, Shugo Tohyama, Akiko Kubo, Tomoteru Yamasaki, Noriko Kabasawa, Kotaro Haga, Hidenori Tani, Yuika Morita-Umei, Tomohiko C Umei, Otoya Sekine and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Yusuke SomaDepartment of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo 144-0041, Japan.
Shugo TohyamaDepartment of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo 144-0041, Japan.
Akiko KuboDepartment of Biochemistry, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Tomoteru YamasakiDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Inage-ku, Chiba 263-8555, Japan.
Noriko KabasawaDepartment of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo 144-0041, Japan.
Kotaro HagaDepartment of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo 144-0041, Japan.
Hidenori TaniDepartment of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo 144-0041, Japan.
Yuika Morita-UmeiDepartment of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo 144-0041, Japan.
Tomohiko C UmeiDepartment of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo 144-0041, Japan.
Otoya SekineDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Masashi NakamuraDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Taijun MoriwakiDepartment of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo 144-0041, Japan.
Sho TanosakiDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Shota SomeyaDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Yujiro KawaiDepartment of Cardiovascular Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Masatoshi OhnoDepartment of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo 144-0041, Japan.
Yoshikazu KishinoDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Hideaki KanazawaDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Jun FujitaDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Ming-Rong ZhangDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Inage-ku, Chiba 263-8555, Japan.
Makoto SuematsuDepartment of Biochemistry, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Keiichi FukudaDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Masaki IedaDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac regenerative therapy using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) has been applied in clinical settings. Herein, we aimed to investigate the

Indexed as

cardiovascular medicinecell biology

Identifiers

PMID39569381
PMCPMC11576393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.